387 related articles for article (PubMed ID: 21298015)
1. Highly selective end-tagged antimicrobial peptides derived from PRELP.
Malmsten M; Kasetty G; Pasupuleti M; Alenfall J; Schmidtchen A
PLoS One; 2011 Jan; 6(1):e16400. PubMed ID: 21298015
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan end-tagging of antimicrobial peptides for increased potency against Pseudomonas aeruginosa.
Pasupuleti M; Chalupka A; Mörgelin M; Schmidtchen A; Malmsten M
Biochim Biophys Acta; 2009 Aug; 1790(8):800-8. PubMed ID: 19345721
[TBL] [Abstract][Full Text] [Related]
4. End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing.
Pasupuleti M; Schmidtchen A; Chalupka A; Ringstad L; Malmsten M
PLoS One; 2009; 4(4):e5285. PubMed ID: 19381271
[TBL] [Abstract][Full Text] [Related]
5. Bacterial killing by heparin-binding peptides from PRELP and thrombospondin.
Malmsten M; Davoudi M; Schmidtchen A
Matrix Biol; 2006 Jul; 25(5):294-300. PubMed ID: 16730966
[TBL] [Abstract][Full Text] [Related]
6. In silico design of polycationic antimicrobial peptides active against Pseudomonas aeruginosa and Staphylococcus aureus.
Hincapié O; Giraldo P; Orduz S
Antonie Van Leeuwenhoek; 2018 Oct; 111(10):1871-1882. PubMed ID: 29626331
[TBL] [Abstract][Full Text] [Related]
7. Boosting antimicrobial peptides by hydrophobic oligopeptide end tags.
Schmidtchen A; Pasupuleti M; Mörgelin M; Davoudi M; Alenfall J; Chalupka A; Malmsten M
J Biol Chem; 2009 Jun; 284(26):17584-94. PubMed ID: 19398550
[TBL] [Abstract][Full Text] [Related]
8. Pse-T2, an Antimicrobial Peptide with High-Level, Broad-Spectrum Antimicrobial Potency and Skin Biocompatibility against Multidrug-Resistant Pseudomonas aeruginosa Infection.
Kang HK; Seo CH; Luchian T; Park Y
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30323036
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, α4-Short, in a Murine Model of Respiratory Infection.
Jiang S; Deslouches B; Chen C; Di ME; Di YP
mBio; 2019 Apr; 10(2):. PubMed ID: 30967458
[TBL] [Abstract][Full Text] [Related]
10. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.
Geitani R; Ayoub Moubareck C; Touqui L; Karam Sarkis D
BMC Microbiol; 2019 Mar; 19(1):54. PubMed ID: 30849936
[TBL] [Abstract][Full Text] [Related]
11. Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.
Knappe D; Ruden S; Langanke S; Tikkoo T; Ritzer J; Mikut R; Martin LL; Hoffmann R; Hilpert K
Amino Acids; 2016 Jan; 48(1):269-80. PubMed ID: 26334348
[TBL] [Abstract][Full Text] [Related]
12. Identification of new dermaseptins with self-assembly tendency: membrane disruption, biofilm eradication, and infected wound healing efficacy.
Song X; Pan H; Wang H; Liao X; Sun D; Xu K; Chen T; Zhang X; Wu M; Wu D; Gao Y
Acta Biomater; 2020 Jun; 109():208-219. PubMed ID: 32276085
[TBL] [Abstract][Full Text] [Related]
13. Role of positively charged residues on the polar and non-polar faces of amphipathic α-helical antimicrobial peptides on specificity and selectivity for Gram-negative pathogens.
Jiang Z; Mant CT; Vasil M; Hodges RS
Chem Biol Drug Des; 2018 Jan; 91(1):75-92. PubMed ID: 28636788
[TBL] [Abstract][Full Text] [Related]
14. In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K.
Gorr SU; Flory CM; Schumacher RJ
PLoS One; 2019; 14(5):e0216669. PubMed ID: 31071184
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2.
Martínez M; Polizzotto A; Flores N; Semorile L; Maffía PC
Microb Pathog; 2020 Feb; 139():103886. PubMed ID: 31778756
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Peptides Secreted From Human Cryopreserved Viable Amniotic Membrane Contribute to its Antibacterial Activity.
Mao Y; Hoffman T; Singh-Varma A; Duan-Arnold Y; Moorman M; Danilkovitch A; Kohn J
Sci Rep; 2017 Oct; 7(1):13722. PubMed ID: 29057887
[TBL] [Abstract][Full Text] [Related]
17. Beta-defensin derived cationic antimicrobial peptides with potent killing activity against gram negative and gram positive bacteria.
Yang M; Zhang C; Zhang MZ; Zhang S
BMC Microbiol; 2018 Jun; 18(1):54. PubMed ID: 29871599
[TBL] [Abstract][Full Text] [Related]
18. Esculentin-1a-Derived Peptides Promote Clearance of Pseudomonas aeruginosa Internalized in Bronchial Cells of Cystic Fibrosis Patients and Lung Cell Migration: Biochemical Properties and a Plausible Mode of Action.
Cappiello F; Di Grazia A; Segev-Zarko LA; Scali S; Ferrera L; Galietta L; Pini A; Shai Y; Di YP; Mangoni ML
Antimicrob Agents Chemother; 2016 Dec; 60(12):7252-7262. PubMed ID: 27671059
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37.
Strömstedt AA; Pasupuleti M; Schmidtchen A; Malmsten M
Antimicrob Agents Chemother; 2009 Feb; 53(2):593-602. PubMed ID: 19029324
[TBL] [Abstract][Full Text] [Related]
20. An optimized analog of antimicrobial peptide Jelleine-1 shows enhanced antimicrobial activity against multidrug resistant P. aeruginosa and negligible toxicity in vitro and in vivo.
Zhou J; Zhang L; He Y; Liu K; Zhang F; Zhang H; Lu Y; Yang C; Wang Z; Fareed MS; Liang X; Yan W; Wang K
Eur J Med Chem; 2021 Jul; 219():113433. PubMed ID: 33878564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
